Seeking Alpha

Steven Breazzano

ABOUT
Steven has done extensive work in the field of synthesis of biologically relevant compounds and new organic reaction development – publishing several papers in prestigious peer-reviewed journals. He has been an active stock market investor for the past 5 years and is currently pursuing the Chartered Financial Analyst (CFA) designation (enrolled for level 2, June 2012) as well as a Ph.D. as an NSF predoctoral fellow in synthetic and biological chemistry first at Columbia University (M.A.) and now at The Scripps Research Institute. He focuses primarily on the valuation of smaller biotechs (100MM to 1 BB market cap).

Disclaimer: I make every reasonable effort to make sure all data I present is factual. It is your ...More
SNAPSHOT
  • Description: Doctoral student. Trading frequency: Monthly
  • Interests: Options, Stocks - long, Stocks - short
COMPANY
Currently, there is no company profile for Steven Breazzano.
BLOG
The Biotech Investment Paradigm The Biotech Investment Paradigm covers biopharmaceutical companies with market caps from approximately $50 million to $1 billion. We believe this niche offers tremendously high return and – when handled properly - acceptable risk. It is our goal to assist investors with a portion of the due diligence ...More
Book
Currently, there are no book details for Steven Breazzano.